The fund’s Class A shares at NAV returned 6.82% for the quarter, underperforming the S&P 500 Index. Click here to read the ...

The Board of Directors of Oramed Pharmaceuticals Inc. (the "Company") announced today that it has unanimously adopted a ...

Magna International emerges as a standout in an auto-equipment industry bolstered by rising electronics demand and ...